Since advanced ovarian cancer is a disease characterized by dissemination of tumors throughout the peritoneal cavity, we hypothesized that NF-κB activation in ovarian tumor-associated macrophages would also limit tumorigenesis in well-defined syngeneic ovarian cancer mouse models. This evidence concerns the gene NFKB1 and ovarian cancer.